Bykerk Vivian P. - Preclinical Rheumatic Disease, An Issue of Rheumatic Disease Clinics, E-Book

HELEN BENHAM, B.App.Sci, MBBS (Hons), FRACP, PhD

Translational Research Institute, The University of Queensland Diamantina Institute, Woolloongabba, Queensland, Australia; The University of Queensland School of Medicine, Brisbane, Queensland, Australia

VIVIAN P. BYKERK, MD, FRCPC

Associate Professor of Medicine, Division of Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, New York

NED CALONGE, MD, MPH

President and CEO, The Colorado Trust; Associate Professor, Department of Family Medicine, University of Colorado School of Medicine; Associate Professor, Department of Epidemiology, Colorado School of Public Health, Denver, Colorado

ROWLAND W. CHANG, MD, MPH

Professor in Medicine, Division of Rheumatology; Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois

KAREN H. COSTENBADER, MD, MPH

Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts

KEVIN D. DEANE, MD, PhD

Division of Rheumatology, University of Colorado School of Medicine, Aurora, Colorado

M. KRISTEN DEMORUELLE, MD

Assistant Professor of Medicine, Division of Rheumatology, University of Colorado School of Medicine, Aurora, Colorado

DAVID T. FELSON, MD, MPH

Professor of Medicine and Epidemiology, Medicine, Boston University School of Medicine, Boston, Massachusetts; Professor of Medicine and Public Health, University of Manchester, Manchester, Lancashire, United Kingdom; Clinical Epidemiology Unit, Boston University, Boston, Massachusetts; NIHR Biomedical Research Unit, University of Manchester, Manchester, United Kingdom

AXEL FINCKH, MD

Division of Rheumatology, University Hospital of Geneva, Genve, Switzerland

DANIELLE M. GERLAG, MD, PhD

Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; GlaxoSmithKline, Cambridge, United Kingdom

RICHARD HODGSON, BM, PhD

NIHR Biomedical Research Unit, University of Manchester, Manchester, United Kingdom

V. MICHAEL HOLERS, MD

Professor of Medicine and Immunology, Division of Rheumatology, University of Colorado School of Medicine, Aurora, Colorado

ROBERT D. INMAN, MD

Professor of Medicine/Immunology, Division of Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada

JUDITH A. JAMES, MD, PhD

Lou Kerr Chair in Biomedical Research; Program Head, Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation; Associate Vice Provost of Clinical and Translational Science and Professor, Departments of Medicine, Pathology, Microbiology and Immunology, Oklahoma Clinical and Translational Science Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

SEOYOUNG C. KIM, MD, ScD, MSCE

Divisions of Pharmacoepidemiology and Pharmacoeconomics and of Rheumatology, Allergy and Immunology, Brigham and Womens Hospital, Boston, Massachusetts

KRISTINE A. KUHN, MD, PhD

Assistant Professor of Medicine, Division of Rheumatology, University of Colorado School of Medicine, Aurora, Colorado

TABITHA N. KUNG, MD, MPH, FRCPC

Clinical Associate, Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada

SOI-CHENG LAW, BSc (Hons)

Translational Research Institute, The University of Queensland Diamantina Institute, Woolloongabba, Queensland, Australia